Sponsored ADR (NASDAQ:SCNI – Get Free Report) saw a large decrease in short interest in the month of January. Scinai Immunotherapeutics Stock Down 5.8%Shares of NASDAQ:SCNI traded down $0.06 during trading on Thursday, reaching $0.97. Get Scinai Immunotherapeutics alerts:Institutional Inflows and OutflowsAn institutional investor recently raised its position in Scinai Immunotherapeutics stock. Citadel Advisors LLC owned approximately 0.90% of Scinai Immunotherapeutics worth $36,000 at the end of the most recent reporting period. Featured ArticlesReceive News & Ratings for Scinai Immunotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scinai Immunotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.